{
    "id": 26680,
    "fullName": "KMT2A fusion",
    "impact": "fusion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "KMT2A fusion indicates a fusion of the KMT2A gene, but the fusion partner is unknown.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 4297,
        "geneSymbol": "KMT2A",
        "terms": [
            "KMT2A",
            "ALL-1",
            "CXXC7",
            "HRX",
            "HTRX1",
            "MLL",
            "MLL1",
            "MLL1A",
            "TRX1",
            "WDSTS"
        ]
    },
    "variant": "fusion",
    "createDate": "07/05/2017",
    "updateDate": "09/17/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11496,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MI-503 inhibited growth of several acute myeloid leukemia (AML) cell lines and primary AML samples harboring KMT2A (MLL) fusions in culture (PMID: 25817203).",
            "molecularProfile": {
                "id": 27975,
                "profileName": "KMT2A fusion"
            },
            "therapy": {
                "id": 6006,
                "therapyName": "MI-503",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9548,
                    "pubMedId": 25817203,
                    "title": "Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25817203"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11382,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, I-BET151 and SGC0946 synergistically inhibited proliferation of patient-derived acute myeloid leukemia cells harboring KMT2A fusions in culture (PMID: 27294782).",
            "molecularProfile": {
                "id": 27975,
                "profileName": "KMT2A fusion"
            },
            "therapy": {
                "id": 5966,
                "therapyName": "I-BET151 + SGC0946",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9271,
                    "pubMedId": 27294782,
                    "title": "Functional interdependence of BRD4 and DOT1L in MLL leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27294782"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20244,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CDKI-73 treatment inhibited Cdk9 kinase activity and viability, and induced apoptosis in acute myeloid leukemia cell lines harboring KMT2A fusions in culture, and inhibited tumor growth and induced regression in a cell line xenograft model (PMID: 30194564).",
            "molecularProfile": {
                "id": 27975,
                "profileName": "KMT2A fusion"
            },
            "therapy": {
                "id": 9298,
                "therapyName": "CDKI-73",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17745,
                    "pubMedId": 30194564,
                    "title": "CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30194564"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11706,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, over expression of Abcb1 was identified as the primary mechanism of acquired Pinometostat (EPZ-5676)-resistance in leukemia cell lines harboring KMT2A (MLL) fusions in culture (PMID: 28428443).",
            "molecularProfile": {
                "id": 28190,
                "profileName": "KMT2A fusion ABCB1 over exp"
            },
            "therapy": {
                "id": 2855,
                "therapyName": "Pinometostat",
                "synonyms": null
            },
            "indication": {
                "id": 1240,
                "name": "leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9714,
                    "pubMedId": 28428443,
                    "title": "Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in MLL-Rearranged Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28428443"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27975,
            "profileName": "KMT2A fusion",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28190,
            "profileName": "KMT2A fusion ABCB1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}